516 related articles for article (PubMed ID: 27526027)
1. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.
Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M
PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027
[TBL] [Abstract][Full Text] [Related]
2. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
3. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
4. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
[TBL] [Abstract][Full Text] [Related]
5. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
[TBL] [Abstract][Full Text] [Related]
6. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
8. Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation.
Hirasaka K; Maeda T; Ikeda C; Haruna M; Kohno S; Abe T; Ochi A; Mukai R; Oarada M; Eshima-Kondo S; Ohno A; Okumura Y; Terao J; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):317-24. PubMed ID: 24064732
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB
Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773
[TBL] [Abstract][Full Text] [Related]
10. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in mouse C2C12 myotubes.
Lee MK; Kim YM; Kim IH; Choi YH; Nam TJ
Mol Med Rep; 2017 Jun; 15(6):3507-3514. PubMed ID: 28393223
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoke and muscle catabolism in C2 myotubes.
Rom O; Kaisari S; Aizenbud D; Reznick AZ
Mech Ageing Dev; 2013; 134(1-2):24-34. PubMed ID: 23262287
[TBL] [Abstract][Full Text] [Related]
12. Reduced myotube diameter, atrophic signalling and elevated oxidative stress in cultured satellite cells from COPD patients.
Pomiès P; Rodriguez J; Blaquière M; Sedraoui S; Gouzi F; Carnac G; Laoudj-Chenivesse D; Mercier J; Préfaut C; Hayot M
J Cell Mol Med; 2015 Jan; 19(1):175-86. PubMed ID: 25339614
[TBL] [Abstract][Full Text] [Related]
13. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ
J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress regulates autophagy in cultured muscle cells of patients with chronic obstructive pulmonary disease.
Gouzi F; Blaquière M; Catteau M; Bughin F; Maury J; Passerieux E; Ayoub B; Mercier J; Hayot M; Pomiès P
J Cell Physiol; 2018 Dec; 233(12):9629-9639. PubMed ID: 29943813
[TBL] [Abstract][Full Text] [Related]
15.
Lee MK; Choi YH; Nam TJ
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955507
[TBL] [Abstract][Full Text] [Related]
16. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
[TBL] [Abstract][Full Text] [Related]
18. Protective role of pretreatment with Anisodamine against sepsis-induced diaphragm atrophy via inhibiting JAK2/STAT3 pathway.
Wang Y; Chu Y; Dai H; Zheng Y; Chen R; Zhou C; Zhong Y; Zhan C; Luo J
Int Immunopharmacol; 2024 May; 133():112133. PubMed ID: 38652962
[TBL] [Abstract][Full Text] [Related]
19. PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.
Castillero E; Alamdari N; Aversa Z; Gurav A; Hasselgren PO
PLoS One; 2013; 8(3):e59726. PubMed ID: 23555761
[TBL] [Abstract][Full Text] [Related]
20. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
